申请人:Gilead Sciences, Inc.
公开号:US20170190737A1
公开(公告)日:2017-07-06
Provided are compounds of Formula I:
and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
提供的是公式I的化合物:
及其药用可接受的盐和酯。这些化合物、组合物和方法对于治疗病毒感染特别是有用的,尤其是丙型肝炎感染。